您的当前位置:首页 > 行业数据 > GZR18正在开展多项2/3期临床试验,包括在美国进行的和替尔泊肽头对头肥胖2期临床
图片属性
图片格式:PNG 图片大小:497KB 图片尺寸:2346*960
同报告图片
 / 4
GZR18正在开展多项2/3期临床试验,包括在美国进行的和替尔泊肽头对头肥胖2期临床_第1页
fCDor5XpqozmoIfpopggICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwg6YCC5bqU55eHICAgICAgIHwg5YiG5pyfICAgfCDpppbmrKHlhaznpLrml6XmnJ8gfCDnm67moIflhaXnu4TkurrmlbAgfCDlnLDljLogICAgIHwg55m76K6w5Y+3ICAgICAgICAgICAgICAgICAgICAgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IOS4gOmhueavlOi+g0daUjE45rOo5bCE5ray5ZKM5Y+4576O5qC86bKB6IK977yIV2Vnb3Z5wq7vvInlnKjogqXog5bmiJbotoXph43miJDkurrlj5for5XogIXkuK3nlpfmlYjlkozlronlhajmgKfnmoRJSUnmnJ/kuLTluornoJTnqbYgfCDogqXog5YgICAgICAgICB8IElJSeacnyAgfCAyMDI1LTA4LTIxICAgfCA0NzEgICAgICAgICAgfCDkuK3lm73lhoXlnLAgfCBOQ1QwNzE1MDk3NTxicj5DVFIyMDI1Mjk3MCB8Cnwg5LiA6aG56K+E5LywR1pSMTjms6jlsITmtrLlnKjppa7po5/lkozov5DliqjmjqfliLbooYDns5bkuI3kvbPnmoQy5Z6L57OW5bC/55eF5oKj6ICF5Lit55aX5pWI5ZKM5a6J5YWo5oCn55qESUlJ5pyf5Li05bqK56CU56m2ICAgICB8IDLlnovns5blsL/nl4UgICAgfCBJSUnmnJ8gIHwgMjAyNC0xMi0yNiAgIHwgMjcwICAgICAgICAgIHwg5Lit5Zu95YaF5ZywIHwgTkNUMDY3NzcyMzg8YnI+Q1RSMjAyNDQ3ODcgfAp8IOS4gOmhueivhOS8sEdaUjE45rOo5bCE5ray5ZyoMuWei+ezluWwv+eXheaIkOS6uuaCo+iAheS4reeWl+aViOWSjOWuieWFqOaAp+eahElJSeacn+S4tOW6iueglOeptiAgICAgICAgICAgICAgICAgICAgICAgfCAy5Z6L57OW5bC/55eFICAgIHwgSUlJ5pyfICB8IDIwMjQtMTItMTcgICB8IDExMDAgICAgICAgICB8IOS4reWbveWGheWcsCB8IE5DVDA2Nzc4OTY3PGJyPkNUUjIwMjQ0NzY0IHwKfCDkuIDpobnmr5TovoNHWlIxOOavjzLlkajkuIDmrKHkuI7mm7/lsJTms4rogr3lkozlronmhbDliYLlnKjogqXog5bmiJbotoXph43lj5for5XogIXkuK3nlpfmlYjlkozlronlhajmgKfnmoRJSUnmnJ/kuLTluornoJTnqbYgICAgIHwg6IKl6IOWICAgICAgICAgfCBJSeacnyAgIHwgMjAyNC0xMi0xNiAgIHwgMjg1ICAgICAgICAgIHwg576O5Zu9ICAgICB8IE5DVDA2NzM3MDQyICAgICAgICAgICAgICAgIHwKfCDkuIDpobnor4TkvLBHWlIxOOazqOWwhOa2suWcqOiCpeiDli/otoXph43miJDkurrlj5for5XogIXkuK3nlpfmlYjlkozlronlhajmgKfnmoRJSUnmnJ/kuLTluornoJTnqbYgICAgICAgICAgICAgICAgICAgICAgIHwg6IKl6IOWICAgICAgICAgfCBJSUnmnJ8gIHwgMjAyNC0xMi0xMSAgIHwgNjMwICAgICAgICAgIHwg5Lit5Zu95YaF5ZywIHwgTkNUMDY3MjgxMjQ8YnI+Q1RSMjAyNDQ2NDcgfAoK5p2l5rqQ77yaaW5zaWdodO+8jOWbvemHkeivgeWIuOeglOeptuaJgA==
GZR18正在开展多项2/3期临床试验,包括在美国进行的和替尔泊肽头对头肥胖2期临床_第2页
GZR18正在开展多项2/3期临床试验,包括在美国进行的和替尔泊肽头对头肥胖2期临床_第3页
GZR18正在开展多项2/3期临床试验,包括在美国进行的和替尔泊肽头对头肥胖2期临床_第4页
GZR18正在开展多项2/3期临床试验,包括在美国进行的和替尔泊肽头对头肥胖2期临床_第5页
所属报告: 【国金证券】医药行业研究:GLP-1专题,产品迭代驱动市场扩容,关注靶点、剂型及联合疗法研发进展-251117(38页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠